Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment

Cites (343)

Items 201–339 of 339

1. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration
   Fernand Labrie, David F. Archer, Céline Bouchard, Michel P. Fortier, Léonello Cusan, José‐Luis Gomez, Ginette Girard, Mira Baron, Normand J. Ayotte, Michèle Moreau et al. · 2009 · Menopause The Journal of The North American Menopause Society
2. A case‐control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well
   Heli K. Lyytinen, Tadeusz A. Dyba, Olavi Ylikorkala, ­Eero Pukkala · 2009 · International Journal of Cancer
3. Cause-Specific Mortality in Women Receiving Hormone Replacement Therapy
   Catherine Schairer, Hans‐Olov Adami, Robert N. Hoover, Ingemar R. Persson · 1997 · Epidemiology
4. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients
   Xuan Bich Trinh, Wiebren A.A. Tjalma, Amin Ph. Makar, G. Buytaert, Joost Weyler, Peter A. van Dam · 2007 · Fertility and Sterility
5. The impact of micronized progesterone on breast cancer risk: a systematic review
   Petra Stute, L. Wildt, Joseph Neulen · 2018 · Climacteric
6. Progesterone and human cognition
   Victor W. Henderson · 2018 · Climacteric
7. Postmenopausal hormone therapy and cognition
   Anna C. McCarrey, Susan M. Resnick · 2015 · Hormones and Behavior
8. Hormone replacement after gynaecological cancer
   Piksi Singh, Martin Klaus Oehler · 2009 · Maturitas
9. Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens
   Jennifer A. Harvey, JoAnn V. Pinkerton, Edmund Chada Baracat, Harry H. Shi, Arkadi A. Chines, Sebastián Mirkin · 2012 · Menopause The Journal of The North American Menopause Society
10. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: Clinical and endometrial responses
    Tytti Raudaskoski, Eija I. Lahti, Antti Kauppila, Meeri A. Apaja-Sarkkinen, Timo Laatikainen · 1995 · American Journal of Obstetrics and Gynecology
11. Noncontraceptive estrogens and myocardial infarction in young women.
    Lynn A. Rosenberg, Dennis Slone, Samuel Shapiro, David W. Kaufman, Paul D. Stolley, Olli S. Miettinen · 1980 · PubMed
12. Postmenopausal estrogen replacement: A long-term cohort study
    Frederic W. Lafferty, Mary E. Fiske · 1994 · The American Journal of Medicine
13. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys
    Charles E. Wood, Thomas C. Register, Cynthia J. Lees, Haiying Chen, Sabrina Kimrey, J. Mark Cline · 2006 · Breast Cancer Research and Treatment
14. Analysis of the Macaca mulatta transcriptome and the sequence divergence between Macaca and human
    Charles L. Magness, P Campion Fellin, Matthew J Thomas, Marcus J. Korth, Michael B. Agy, Sean C Proll, Matthew Fitzgibbon, Christina Scherer, Douglas G. Miner, Michael G. Katze et al. · 2005 · Genome biology
15. Estrogen Replacement Therapy and Prognosis after First Myocardial Infarction
    Katherine M. Newton, Andrea Z. LaCroix, Barbara McKnight, Robert H. Knopp, David S. Siscovick, Susan R. Heckbert, N. S. Weiss · 1997 · American Journal of Epidemiology
16. Noncontraceptive Estrogens and Nonfatal Myocardial Infarction
    Hershel Jick · 1978 · JAMA
17. Estrogen Replacement Therapy in Women with Prior Diagnosis and Treatment for Breast Cancer
    Rena Vassilopoulou‐Sellin, Richard L. Theriault, Mary Jean Klein · 1997 · Gynecologic Oncology
18. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women
    Barry G. Wren, Susan M. Champion, Karen Willetts, Robert Zoa Manga, John Eden · 2003 · Menopause The Journal of The North American Menopause Society
19. Cardiovascular disease and hormone replacement treatment: a pilot case-control study.
    S Adam, V Williams, Martin P. Vessey · 1981 · BMJ
20. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials
    Claudia M. Greiser, Eberhard M. Greiser, Martina Dören · 2005 · Human Reproduction Update
21. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause
    Hugh Stott Taylor, Aya Tal, Lubna Pal, Fangyong Li, Dennis M. Black, Eliot A. Brinton, Matthew Jay Budoff, Marcelle Ivonne Cedars, Wei Du, Howard Neil Hodis et al. · 2017 · JAMA Internal Medicine
22. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment
    Frederick Nicholas Naftolin, Jenna Friedenthal, Richard H. Nachtigall, Lila E. Nachtigall · 2019 · F1000Research
23. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy
    RANDI DUGAL, KNUT HESLA, Terje Sørdal, KATHE HELEN AASE, ODDVAR LILLEEIDET, E Wickström · 2000 · Acta Obstetricia Et Gynecologica Scandinavica
24. The new conundrum: do estrogens have any cardiovascular benefits?
    Thomas B. Clarkson · 2002 · PubMed
25. Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis
    JoAnn V. Pinkerton, David F. Archer, Wulf H. Utian, José Carlos Menegoci, Amy B. Levine, Arkadi A. Chines, Ginger D. Constantine · 2009 · Menopause The Journal of The North American Menopause Society
26. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: A systematic review and meta-analysis
    Dong Li, Chengyi Ding, Lihua Qiu · 2015 · Gynecologic Oncology
27. Lowest Effective Transdermal 17β-Estradiol Dose for Relief of Hot Flushes in Postmenopausal Women
    Gloria Ann Bachmann, Matthias Schaefers, Alkaz Uddin, Wulf H. Utian · 2007 · Obstetrics and Gynecology
28. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study
    Natalie Rasgon, Jennifer J. Dunkin, Lynn A. Fairbanks, Lori L. Altshuler, Co Troung, Shana Elman, Tonita Wroolie, Martina V. Brunhuber, Andrea J. Rapkin · 2006 · Journal of Psychiatric Research
29. Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making
    JoAnn E. Manson, Jeffrey M. Ames, Marla Shapiro C.M., Margery L S Gass, Jan Leslie Shifren, Cynthia A. Stuenkel, JoAnn V. Pinkerton, Andrew M. Kaunitz, Diane Todd Pace, Risa Kagan et al. · 2014 · Menopause The Journal of The North American Menopause Society
30. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy
    Eero Varila, Torsten Wahlström, Ilkka Rauramo · 2001 · Fertility and Sterility
31. Progestins and cardiovascular risk markers
    Regine L. Sitruk-Ware · 2000 · Steroids
32. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms
    Leon Speroff · 2003 · Obstetrics and Gynecology
33. Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial
    Mike Trower, Richard A. Anderson, Elizabeth Ballantyne, Hadine Joffe, Mary Kerr, Steve Pawsey · 2020 · Menopause The Journal of The North American Menopause Society
34. Effect of Body Mass on the Association between Estrogen Replacement Therapy and Mortality among Elderly US Women
    Carmen Rodríguez, Eugenia E. Calle, Alpa V. Patel, Lilith M. Tatham, Eric J. Jacobs, Michael J. Thun · 2001 · American Journal of Epidemiology
35. Estrogen use and myocardial infarction risk: A case-control study
    Moysés Szklo, James Tonascia, Leon Gordis, Ilene Bloom · 1984 · Preventive Medicine
36. Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy
    Jerilynn C. Prior, Jason D. Nielsen, Christine L. Hitchcock, Lucy A. Williams, Yvette M. Vigna, Charmaine B. Dean · 2007 · Clinical Science
37. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.
    Victoria L. Handa, Kevin E. Bachus, William W. Johnston, Stanley J. Robboy, Charles B. Hammond · 1994 · PubMed
38. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies
    Steven E. Reís, Richard Holubkov, James B. Young, B.G. White, Jay N. Cohn, Arthur Michael Feldman · 2000 · Journal of the American College of Cardiology
39. Systemic absorption of progesterone from Progest cream in postmenopausal women
    A Cooper, C Spencer, Malcolm I. Whitehead, D Ross, G. Barnard, W. P. Collins · 1998 · The Lancet
40. Differential Biochemical and Cellular Actions of Premarin Estrogens: Distinct Pharmacology of Bazedoxifene-Conjugated Estrogens Combination
    Thomas J. Berrodin, Ken C. N. Chang, Barry S. Komm, Leonard P. Freedman, Sunil Nagpal · 2008 · Molecular Endocrinology
41. Committee Opinion No. 532
    2012 · Obstetrics and Gynecology
42. Hormone replacement therapy and peripheral arterial disease: the Rotterdam study.
    Iris C.D. Westendorp, Bas A. in't Veld, Diederick E. Grobbee, H. A. P. Pols, W T Meijer, Albert Hofman, Jacqueline C.M. Witteman · 2000 · PubMed
43. Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?
    A. Ayhan, Çağatay Taşkıran, Selin Şimşek, Atike Sever · 2006 · International Journal of Gynecological Cancer
44. Case-control study of oestrogen replacement therapy and risk of cervical cancer
    Fabio Parazzini, Carlo La Vecchia, Eva Negri, Silvia Franceschi, Simona Moroni, Liliane Chatenoud, Giorgio Bolis · 1997 · BMJ
45. The Rochester Coronary Heart Disease Project: Effect of Cigarette Smoking, Hypertension, Diabetes, and Steroidal Estrogen Use on Coronary Heart Disease Among 40- to 59-Year-Old Women, 1960 Through 1982
    C. Mary Beard, Thomas E. Kottke, John Fred Annegers, David Ballard · 1989 · Mayo Clinic Proceedings
46. Extended-release oxybutynin therapy for vasomotor symptoms in women: a randomized clinical trial
    James A. Simon, Tatiana Gaines, Katherine D. LaGuardia · 2016 · Menopause The Journal of The North American Menopause Society
47. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy
    P.-Å. Holmgren, Marianne Lindskog, Bo von Schoultz · 1989 · Maturitas
48. Breast Cancer Survival and Hormone Replacement Therapy
    Philip John DiSaia, Wendy R. Brewster, Argyrios Ziogas, Hoda Anton‐Culver · 2000 · American Journal of Clinical Oncology
49. Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study
    Carolyn J. Crandall, Kathleen M. O'Reilly Hovey, Chris Andrews, Jane A. Cauley, Marcia L. Stefanick, CHRISANDRA L. SHUFELT, Ross L. Prentice, Andrew M. Kaunitz, Charles B. Eaton, Jean Wactawski‐Wende et al. · 2017 · Menopause The Journal of The North American Menopause Society
50. Menopausal Hormone Therapy and Subsequent Risk of Specific Invasive Breast Cancer Subtypes in the California Teachers Study
    Tanmai Saxena, Eunjung Lee, Katherine DeLellis Henderson, Christina A. Clarke, Dee W. West, Sarah F. Marshall, Dennis Deapen, Leslie Bernstein, Giske Ursin · 2010 · Cancer Epidemiology Biomarkers & Prevention
51. Menopausal Hormone Therapy and Mortality: A Systematic Review and Meta-Analysis
    Khalid Benkhadra, Khaled S. Mohammed, Alaa Al Nofal, Barbara Gisella Carranza Leon, Fares Alahdab, Stephanie S. Faubion, Víctor M. Montori, Abd Moain Abu Dabrh, Jorge Alberto Zúñiga Hernández, Larry J. Prokop et al. · 2015 · The Journal of Clinical Endocrinology & Metabolism
52. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells
    Aurélie Courtin, Laudine Communal, Myriam Vilasco, Daniela Cimino, Najat Mourra, Michele De Bortoli, Daniela Taverna, Anne‐Marie Faussat, Marc Chaouat, Patricia Forgez et al. · 2011 · Breast Cancer Research and Treatment
53. Estrogen replacement therapy for menopausal women with a history of breast carcinoma
    Rena Vassilopoulou‐Sellin, Deborah S. Cohen, Gabriel N. Hortobágyi, Mary Jean Klein, Marsha D. McNeese, S. Eva Singletary, Terry L. Smith, Richard L. Theriault · 2002 · Cancer
54. Hormone Replacement Therapy after Treatment of Breast Cancer: Effects on Postmenopausal Symptoms, Bone Mineral Density and Recurrence Rates
    Matthias W. Beckmann, David Jap, Sirus Djahansouzi, Carolin Nestle-Krämling, Bettina Kuschel, Peter Dall, Carsten Brumm, Hans Bender · 2001 · Oncology
55. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage
    Bruce B. Ettinger · 2005 · The American Journal of Medicine
56. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: A systematic review and meta-analysis
    Konstantinos A. Toulis, Thrasyvoulos Tzellos, Dimitrios Kouvelas, Dimitrios G. Goulis · 2009 · Clinical Therapeutics
57. The levonorgestrel intrauterine system for use in peri- and postmenopausal women
    Regine L. Sitruk-Ware · 2007 · Contraception
58. Serum Lipid Profile Improved by Ultra-Low Doses of 17β-Estradiol in Elderly Women1
    Tord Naessén, Kenny Rodriguez-Macias, Hans Lithell · 2001 · The Journal of Clinical Endocrinology & Metabolism
59. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes
    Manish Modi, Waljit Singh Dhillo · 2018 · Neuroendocrinology
60. Noncontraceptive Estrogens and Myocardial Infarction in Young Women
    Lynn A. Rosenberg · 1980 · JAMA
61. Influence of the Maturity of the Vaginal Epithelium upon the Absorption of Vaginally Administered Estradiol-17β and Progesterone in Postmenopausal Women
    Helmut Pschera, Anders Hjerpe, Kjell Carlström · 2010 · Gynecologic and Obstetric Investigation
62. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment
    Marjetka Uršič-Vrščaj, Sonja Bebar · 1999 · European Journal of Surgical Oncology
63. Intrauterine application of progestins in hormone replacement therapy: a review
    Frits E. Riphagen · 2000 · Climacteric
64. Testosterone therapy for sexual dysfunction in postmenopausal women
    Z.R. Hubayter, James A. Simon · 2008 · Climacteric
65. Early Menopause: Primary Ovarian Insufficiency and Surgical Menopause
    Pinar H. Kodaman · 2010 · Seminars in Reproductive Medicine
66. Update on Menopausal Hormone Therapy for Fracture Prevention
    Jan J. Stepan, Hana Hruskova, Miloslav Kverka · 2019 · Current Osteoporosis Reports
67. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned
    JoAnn E. Manson, Shari S. Bassuk, Andrew M. Kaunitz, JoAnn V. Pinkerton · 2020 · Menopause The Journal of The North American Menopause Society
68. Menopause, hormone replacement and gynaecological cancers
    Lynsey Hinds, John Price · 2010 · Menopause international
69. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials
    Krantarat Peeyananjarassri, Rod Baber · 2005 · Climacteric
70. A cohort study of hormone replacement therapy given to women previously treated for breast cancer
    Jennifer E. Dew, JA Eden, Elaine Beller, Christopher John Magarey, Peter E. Schwartz, Paul Crea, Barry G. Wren · 1998 · Climacteric
71. Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study
    Asma Arabi · 2003 · Human Reproduction
72. Rationale for use of lower estrogen doses for postmenopausal hormone therapy
    Bruce B. Ettinger · 2007 · Maturitas
73. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Rena Vassilopoulou‐Sellin, Rachel Leigh Theriault · 1994 · PubMed
74. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women
    Barry G. Wren, Katy V. McFarland, Lyndall Edwards, PJ OShea, S. Sufi, B. Gross, John Eden · 2000 · Climacteric
75. No Increase in Fractures after Stopping Hormone Therapy: Results from the Women’s Health Initiative
    Nelson B. Watts, Jane A. Cauley, Rebecca D. Jackson, Andrea Z. LaCroix, Cora Elizabeth Lewis, JoAnn E. Manson, Joan Marie Neuner, Lawrence S. Phillips, Marcia L. Stefanick, Jean Wactawski‐Wende et al. · 2016 · The Journal of Clinical Endocrinology & Metabolism
76. Menopausal Hormone Therapy
    Jan Leslie Shifren, Carolyn J. Crandall, JoAnn E. Manson · 2019 · JAMA
77. Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?
    Howard Neil Hodis, Philip M. Sarrel · 2018 · Climacteric
78. Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women
    Barbara B. Sherwin, Miglena Grigorova · 2011 · Fertility and Sterility
79. Endometrial thickness and uterine diameter not affected by ultralow doses of 17β-estradiol in elderly women
    Tord Naessén, Kenny A. Rodriguez‐Wallberg · 2002 · American Journal of Obstetrics and Gynecology
80. Estrogen replacement therapy in breast cancer survivors: a matched-controlled series
    David A. Decker, Jane Pettinga, Nancy VanderVelde, Raywin Huang, Larry Llyn Kestin, John H. Burdakin · 2003 · Menopause The Journal of The North American Menopause Society
81. Intrauterine administration of levonorgestrel 5 and 10 μg/24 hours in perimenopausal hormone replacement therapy
    Lars‐Olof Wollter‐Svensson, Elisabeth Stadberg, Kerstin Malm Andersson, Lars‐Åke Mattsson, Viveca Odlind, Ingemar R. Persson · 1997 · Acta Obstetricia Et Gynecologica Scandinavica
82. Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study
    Carol J. Fabian, Lauren Elizabeth Nye, Kandy R. Powers, Jennifer L. Nydegger, Amy L. Kreutzjans, Teresa A. Phillips, Trina Metheny, Onalisa D. Winblad, Carola Maria Zalles, Christy R. Hagan et al. · 2019 · Cancer Prevention Research
83. A study to evaluate serum and urinary hormone levels following short and long term administration of two regimens of progesterone cream in postmenopausal women
    Beverly J. Carey, Adam H. Carey, Sanjaykumar R. Patel, Graham Carter, John W. W. Studd · 2000 · BJOG An International Journal of Obstetrics & Gynaecology
84. Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women
    David Ross, Alison J. Cooper, John Pryse-Davies, Christine Bergeron, William P. Collins, Malcolm I. Whitehead · 1997 · American Journal of Obstetrics and Gynecology
85. Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial
    Rowan T. Chlebowski, Heather A. Wakelee, Mary B. Pettinger, Thomas E. Rohan, Jingmin Liu, Michael Steven Simon, Hilary Aurora Tindle, Catherine R. Messina, Karen Johnson, Ann G. Schwartz et al. · 2015 · Clinical Lung Cancer
86. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors
    Fang-Ping Chen, Ning Lee, Yung-Kui Soong, Ko‐En Huang · 2001 · Menopause The Journal of The North American Menopause Society
87. A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women
    Beverly Benster, Adam H. Carey, Fred Wadsworth, Arvind Vashisht, Claudine Domoney, John W. W. Studd · 2009 · Menopause international
88. Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease
    Tonita Wroolie, Heather A. Kenna, Katherine Ellie Williams, Natalie Rasgon · 2015 · American Journal of Geriatric Psychiatry
89. Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women
    Bruce B. Ettinger, Lori Bainton, David H. Upmalis, John T. Citron, A Vangessel · 1997 · American Journal of Obstetrics and Gynecology
90. Comparison of intravaginal 6.5 mg (0.50%) prasterone, 0.3 mg conjugated estrogens and 10 μg estradiol on symptoms of vulvovaginal atrophy
    David F. Archer, Fernand Labrie, Marlene Montesino, Céline Martel · 2017 · The Journal of Steroid Biochemistry and Molecular Biology
91. Percutaneous administration of progesterone: blood levels and endometrial protection
    Frank Z. Stanczyk, Richard J. Paulson, Subir Roy · 2005 · Menopause The Journal of The North American Menopause Society
92. Inhibitory effects of a bazedoxifene/conjugated equine estrogen combination on human breast cancer cells in vitro.
    Yan Song, R. Santen, Ji-Ping Wang, W. Yue · 2013 · Endocrinology
93. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention
    Pinkerton, J. V., Pickar, J. H., Racketa, J., Mirkin, S. · 2012 · Climacteric
94. Vaginal progesterone in menopause: Crinone(R) 4% in cyclical and constant combined regimens
    Dominique de Ziegler, R.A. Ferriani, LAM Moraes, Carlo Bulletti · 2000 · Human Reproduction
95. Underlying Breast Cancer Risk and Menopausal Hormone Therapy
    Richard J. Santen, Daniel F. Heitjan, Anne Gompel, Mary Ann Lumsden, JoAnn V. Pinkerton, Susan R. Davis, Cynthia A. Stuenkel · 2020 · The Journal of Clinical Endocrinology & Metabolism
96. A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy
    Merja B. Marttunen, Päivi S. Hietanen, Seppo O Pyrhönen, Aila E. Tiitinen, Olavi Ylikorkala · 2001 · Maturitas
97. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy
    JoAnn V. Pinkerton, James H. Pickar · 2015 · Menopause The Journal of The North American Menopause Society
98. Prevention of secondary hyperparathyroidism and hip fracture in elderly women with calcium and vitamin D3 supplements
    M. C. Chapuy, Pierre Jean Meunier · 1996 · Osteoporosis International
99. Recent Patterns of Hormone Replacement Therapy Use in a Large Managed Care Organization
    EVELYN P. WHITLOCK, Richard E. Johnson, THOMAS M. VOGT · 1998 · Journal of Women s Health
100. Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies
     Sohyun Kim, Yeonsook Ko, Hwa Jeong Lee, Jung‐Eun Lim · 2018 · Breast Cancer Research and Treatment
101. Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis.
     Yun Fu, Zhigang Zhuang · 2014 · PubMed Central
102. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women
     Fatih Şendağ, Nedim Karadadaş, Serdar Özşener, Onur Bilgin · 2002 · Archives of Gynecology and Obstetrics
103. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms
     Farook Al‐Azzawi, Helen M. Buckler · 2003 · Climacteric
104. Hormone replacement therapy after treatment for a gynaecological malignancy
     Rachel Louise O'Donnell, Katherine M. Clement, Richard John Edmondson · 2015 · Current Opinion in Obstetrics & Gynecology
105. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women
     Tze Kin Lau, Din Wan, So Fan Yim, John Elsby Sanderson, Christopher J. Haines · 1998 · Fertility and Sterility
106. Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause
     Mary Lou Voytko, Gregory Paul Tinkler, Carole L. Browne, Joseph R. Tobin · 2009 · American Journal of Primatology
107. Ospemifene use in postmenopausal women
     Luigi Gennari, Daniela Merlotti, Fabrizio Valleggi, Ranuccio Nuti · 2009 · Expert Opinion on Investigational Drugs
108. Estrogen replacement therapy in patients with early breast cancer
     Puthugramam K. Natrajan, R. Don Gambrell · 2002 · American Journal of Obstetrics and Gynecology
109. Molecular characterization of a B-ring unsaturated estrogen: Implications for conjugated equine estrogen components of Premarin
     Robert W. Hsieh, Shyamala S. Rajan, Sanjay K. Sharma, Geoffrey L. Greene · 2007 · Steroids
110. Estrogen replacement therapy in breast cancer survivors
     Franco Guidozzi · 1999 · International Journal of Gynecology & Obstetrics
111. Low-dosage esterified estrogens opposed by progestin at 6-month intervals
     Bruce B. Ettinger · 2001 · Obstetrics and Gynecology
112. Endometrial effects, bleeding control, and compliance with a new postmenopausal hormone therapy regimen based on transdermal estradiol gel and every-other-day vaginal progesterone in capsules: a 3-year pilot study
     Ettore Cicinelli, Dominique de Ziegler, Raffaello Alfonso, Roberto Nicoletti, Marina Bellavia, Giuseppe Colafiglio · 2005 · Fertility and Sterility
113. Testosterone Dose-Response Relationships With Cardiovascular Risk Markers in Androgen-Deficient Women: A Randomized, Placebo-Controlled Trial
     Grace Tzu-Wei Huang, Elizabeth Tang, Adam Aakil, Stephan William Anderson, Hernan J. Jara, Maithili N. Davda, Helene Stroh, Thomas G. Travison, Shalender Bhasin, Shehzad Sultan Basaria · 2014 · The Journal of Clinical Endocrinology & Metabolism
114. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study
     CHRISANDRA L. SHUFELT, C. Noel Bairey Merz, Mary B. Pettinger, Lydia Choi, Rowan T. Chlebowski, Carolyn J. Crandall, Simin Liu, Dorothy S. Lane, Ross L. Prentice, JoAnn E. Manson · 2018 · Menopause The Journal of The North American Menopause Society
115. The rationale, design, and baseline characteristics of the Women's Health Initiative Memory Study of Younger Women (WHIMS-Y)
     Leslie Vaughan, Mark Andrew Espeland, Beverly M. Snively, Sally Ann Shumaker, Stephen R. Rapp, Jill Shupe, Jennifer G. Robinson, Gloria E. Sarto, Susan M. Resnick · 2013 · Brain Research
116. Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?
     Hanna Bukowska, Stanisław Stanosz, Ewa Żochowska, Barbara Millo, Krzysztof Sieja, Kornel Chełstowski, Marek Naruszewicz · 2004 · Metabolism
117. Estrogen Replacement Therapy After Breast Cancer: A 12-Year Follow-Up
     George N. Peters, Tomasina Fodera, Jennifer L. Sabol, Stephen E. Jones, David Euhus · 2001 · Annals of Surgical Oncology
118. Ddx4+ Oogonial Stem Cells in Postmenopausal Women’s Ovaries: A Controversial, Undefined Role
     Erica Silvestris, Paola Cafforio, Claudia Felici, Gennaro Cormio, Stella D’Oronzo · 2019 · Cells
119. Timing of cyclic estradiol treatment differentially affects cognition in aged female rhesus monkeys.
     Mark G. Baxter, Anthony C. Santistevan, Eliza Bliss‐Moreau, John H. Morrison · 2018 · Behavioral Neuroscience
120. Low-dose transdermal estradiol for vasomotor symptoms
     Jennifer A. Corbelli, Nader Shaikh, Charles B. Wessel, Rachel Hess · 2014 · Menopause The Journal of The North American Menopause Society
121. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo
     Aleksandra M. Ochnik, Nicole L. T. Moore, Tanja Jankovic‐Karasoulos, Tina Bianco‐Miotto, Natalie K. Ryan, Mervyn Thomas, Stephen N. Birrell, Lisa M. Butler, Wayne D. Tilley, Theresa E. Hickey · 2013 · Menopause The Journal of The North American Menopause Society
122. Oral Contraceptives, Postmenopausal Hormones, and Risk of Asynchronous Bilateral Breast Cancer: The WECARE Study Group
     Jane C. Figueiredo, Leslie Bernstein, Marinela Capanu, Kathleen E. Malone, Charles F. Lynch, Hoda Anton‐Culver, Marilyn A. Stovall, Lisbeth Bertelsen, Robert W. Haile, Jonine L. Bernstein · 2008 · Journal of Clinical Oncology
123. Relation between hormone replacement therapy in women and coronary artery disease estimated by electron beam tomography
     Vallerie V. McLaughlin, Julie Anne Hoff, Stuart Rich · 1997 · American Heart Journal
124. The Clinical Utility of Compounded Bioidentical Hormone Therapy
     Board on Health Sciences Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine · 2020 · National Academies Press eBooks
125. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use
     Jan Brynhildsen, Mats L. Hammar · 2004 · Maturitas
126. Intrauterine administration of levonorgestrel in two low doses in HRT. A randomized clinical trial during one year: effects on lipid and lipoprotein metabolism
     Lars‐Olof Wollter‐Svensson, Elisabeth Stadberg, Kerstin Malm Andersson, Lars‐Åke Mattsson, Viveca Odlind, Ingemar R. Persson · 1995 · Maturitas
127. Action of 25 microg 17beta-oestradiol vaginal tablets in the treatment of vaginal atrophy in Greek postmenopausal women; clinical study.
     Ch Akrivis, M Varras, A Thodos, G Hadjopoulos, A Bellou, N Antoniou · 2003 · PubMed
128. Compounded bioidentical menopausal hormone therapy – a physician perspective
     Cynthia A. Stuenkel · 2020 · Climacteric
129. Safety and comfort of long-term continuous combined transdermal estrogen and intrauterine levonorgestrel administration for postmenopausal hormone substitution – a review
     Dirk A. Wildemeersch · 2016 · Gynecological Endocrinology
130. The Effect of Menopausal Hormone Therapies on Breast Cancer
     Valerie A. Flores, Hugh Stott Taylor · 2015 · Endocrinology and Metabolism Clinics of North America
131. The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy
     JoAnn V. Pinkerton, Stephanie S. Faubion, Andrew M. Kaunitz, JAMES H. LIU, JoAnn E. Manson, Nanette F. Santoro, Jan Leslie Shifren, Cynthia A. Stuenkel · 2020 · Menopause The Journal of The North American Menopause Society
132. Which progestogen is more likely to increase the risk of fatal myocardial infarction: A combination of epidemiological and trial evidence
     Farook Al‐Azzawi, John Russell Thompson, John S. Stevenson · 2005 · Maturitas
133. Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women
     Ramazan Dansuk, Orhan Ünal, Yasemin Karageyim Karşıdağ, Esra Esim, C Turan · 2004 · Gynecological Endocrinology
134. Systemic Lupus Erythematosus in a Multiethnic US Cohort, LUMINA (XLIX)
     Mónica Fernández, Gerald McGwin, Rosa M. Andrade, Holly M. Bastian, Barri J. Fessler, John D. Reveille, Luis M. Vilá, Graciela S. Alarcón · 2008 · JCR Journal of Clinical Rheumatology
135. Managing Menopause by Combining Evidence With Clinical Judgment
     Valerie A. Flores, Lubna Pal · 2018 · Clinical Obstetrics & Gynecology
136. Estradiol and follicle-stimulating hormone levels in oophorectomized women using vaginal estrogen.
     Nimit Taechakraichana, A Intraragsakul, Krasean Panyakhamlerd, Pranee Numchaisrika, Khunying Kobchitt Limpaphayom · 1997 · PubMed
137. Levonorgestrel–releasing intra–uterine systems (LNG-IUS) and breast cancer
     Patrick Neven, Frédéric C. Amant, Willy A. J. Poppe, Rudy Van den Broecke · 2009 · Fertility and Sterility
138. Menopause and the epidemiology of cardiovascular disease in women.
     Jeffrey A. Perlman, Pamela H. Wolf, Fanchon F. Finucane, Jennifer H. Madans · 1989 · PubMed
139. The critical window hypothesis: implications of cognitive outcomes from the ELITE clinical trial
     Victor W. Henderson, Howard Neil Hodis, Jan A. St. John, Carol A. McCleary, Frank Z. Stanczyk, Donna Shoupe, Naoko Kono, Laurie Labree Dustin, Hooman Allayee, Wendy Jean Mack · 2015 · Maturitas